Thursday, November 15, 2018
BTI Biotechnology Institute proposes a minimally invasive alternative for this surgical treatment: the new family of 3.0 implants
Transverse bone defects are a common situation for dentists which often implies the approach of bone augmentation techniques that prolong treatment times and increase costs and surgical morbidity.
Faithful to its biological treatment approaches, BTI Biotechnology Institute proposes a minimally invasive alternative for rehabilitation of narrow ridges: the new 3.0 line of implants, characterised by a prosthodontic platform and body diameter of 3 mm, as well lengths` versatility. Available in diameters 2,5 - 3,0 - 3,3 mm.
The main purpose of these implants is to treat total and/or partial edentulisms with transversal alveolar atrophy, reducing the need for bone augmentation also the surgical complications and time.
